GB Sciences, Inc.
(Other OTC/NBB : GBLX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc. 1.60%78.211.0%$1948.71m
AMGNAmgen, Inc. -1.66%205.411.3%$885.20m
REGNRegeneron Pharmaceuticals, Inc. -1.09%493.322.6%$821.01m
BIIBBiogen, Inc. -1.30%300.511.5%$730.72m
MRNAModerna, Inc. 4.94%34.840.0%$587.89m
VRTXVertex Pharmaceuticals, Inc. -1.59%238.311.9%$585.26m
ILMNIllumina, Inc. -3.48%263.503.5%$455.53m
ALXNAlexion Pharmaceuticals, Inc. -0.64%89.772.0%$278.42m
AAgilent Technologies, Inc. -2.63%70.391.6%$217.41m
INCYIncyte Corp. 1.97%78.592.5%$187.57m
EXASEXACT Sciences Corp. -3.21%55.7521.0%$173.77m
BMRNBioMarin Pharmaceutical, Inc. -2.15%84.214.3%$161.37m
SGENSeattle Genetics, Inc. -1.82%116.516.1%$157.34m
NVAXNovavax, Inc. 12.63%15.61114.7%$131.54m
SRPTSarepta Therapeutics, Inc. -2.46%93.6214.0%$100.23m

Company Profile

GB Sciences, Inc. engages in the biopharmaceutical research and development of cannabis plant into medicines, therapies, and treatments. It intends to identify and develop cannabis-based therapies that target specific diseases or medical conditions. The company was founded on April 4, 2001 and is headquartered in Las Vegas, NV.